CH624383A5 - - Google Patents

Download PDF

Info

Publication number
CH624383A5
CH624383A5 CH1480376A CH1480376A CH624383A5 CH 624383 A5 CH624383 A5 CH 624383A5 CH 1480376 A CH1480376 A CH 1480376A CH 1480376 A CH1480376 A CH 1480376A CH 624383 A5 CH624383 A5 CH 624383A5
Authority
CH
Switzerland
Prior art keywords
acid
formula
pharmaceutically acceptable
compound
fibrin
Prior art date
Application number
CH1480376A
Other languages
German (de)
English (en)
Inventor
Clifford Ronald Hughes
Stephen John Jackson
John Preston
Peter Leslie Walton
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH624383A5 publication Critical patent/CH624383A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH1480376A 1975-11-25 1976-11-24 CH624383A5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48402/75A GB1559977A (en) 1975-11-25 1975-11-25 Amines

Publications (1)

Publication Number Publication Date
CH624383A5 true CH624383A5 (es) 1981-07-31

Family

ID=10448487

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1480376A CH624383A5 (es) 1975-11-25 1976-11-24

Country Status (28)

Country Link
US (1) US4105790A (es)
JP (2) JPS5265240A (es)
AR (1) AR215871A1 (es)
AT (1) AT348993B (es)
AU (1) AU503657B2 (es)
BE (1) BE848707A (es)
CA (1) CA1068695A (es)
CH (1) CH624383A5 (es)
CS (1) CS196333B2 (es)
DD (1) DD127474A5 (es)
DE (1) DE2653635C2 (es)
DK (1) DK531276A (es)
ES (2) ES453632A1 (es)
FI (1) FI763399A (es)
FR (1) FR2332747A1 (es)
GB (1) GB1559977A (es)
IE (1) IE44030B1 (es)
IL (1) IL50904A (es)
IN (1) IN145003B (es)
LU (1) LU76251A1 (es)
NL (1) NL7613081A (es)
NO (1) NO764012L (es)
NZ (1) NZ182581A (es)
PL (2) PL105491B1 (es)
PT (1) PT65892B (es)
SE (1) SE7613079L (es)
SU (1) SU722481A3 (es)
ZA (1) ZA766696B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02130656U (es) * 1989-03-31 1990-10-29
JPH028457U (es) * 1988-07-01 1990-01-19
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
HU226037B1 (en) 1993-06-25 2008-03-28 Aventis Inc Process for producing antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives and novel intermediates
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6700012B2 (en) 1998-07-02 2004-03-02 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
FR2880887B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
EP3170844A4 (en) * 2014-07-16 2018-01-10 Adeka Corporation Photosensitive composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques

Also Published As

Publication number Publication date
PL193861A1 (pl) 1978-03-28
DD127474A5 (es) 1977-09-28
JPS5265240A (en) 1977-05-30
IN145003B (es) 1978-08-12
IL50904A (en) 1980-02-29
LU76251A1 (es) 1977-12-13
ES465152A1 (es) 1978-10-01
SU722481A3 (ru) 1980-03-15
BE848707A (fr) 1977-05-24
JPS6360004B2 (es) 1988-11-22
JPS61158922A (ja) 1986-07-18
ATA870976A (de) 1978-08-15
DE2653635C2 (de) 1986-10-02
AU1962576A (en) 1978-05-25
NO764012L (es) 1977-05-26
AR215871A1 (es) 1979-11-15
AU503657B2 (en) 1979-09-13
US4105790A (en) 1978-08-08
PL105799B1 (pl) 1979-10-31
DK531276A (da) 1977-05-26
ES453632A1 (es) 1978-03-16
FR2332747A1 (fr) 1977-06-24
GB1559977A (en) 1980-01-30
CS196333B2 (en) 1980-03-31
FI763399A (es) 1977-05-26
IE44030L (en) 1977-05-25
IE44030B1 (en) 1981-07-29
FR2332747B1 (es) 1980-03-14
PL105491B1 (pl) 1979-10-31
DE2653635A1 (de) 1977-06-02
PT65892A (en) 1976-12-01
SE7613079L (sv) 1977-05-26
PT65892B (en) 1978-05-18
NZ182581A (en) 1978-09-20
AT348993B (de) 1979-03-12
NL7613081A (nl) 1977-05-27
JPS6120538B2 (es) 1986-05-22
CA1068695A (en) 1979-12-25
ZA766696B (en) 1977-10-26

Similar Documents

Publication Publication Date Title
DE2204195A1 (de) Neue 2-Hydroxymethyl-3-hydroxy-6-(l-hydroxy-2-aminoäthyi)-pyridine
DE2166398C3 (de) 43-Tetrazolo [1,5-a] chinoline und Verfahren zu ihrer Herstellung
CH624383A5 (es)
DE2438399C3 (de) a-substituierte Benzhydrolderivate und ihre Salze, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben
DE1768655B2 (es)
DE2748291B2 (de) Substituierte 13-Benzodioxan-4one und Verfahren zu ihrer Herstellung sowie Verwendung dieser Verbindungen bei der Bekämpfung von Entzündungen
AT363074B (de) Verfahren zur herstellung von neuen 1-amino-niedrig-alkyl-3,4-diphenyl-1h-pyrazolen und ihren salzen
CH643862A5 (de) Bis(4-demethoxydaunorubicin)dihydrazon-derivate und sie enthaltende pharmazeutische zubereitungen.
CH645094A5 (de) Hydrazon-verbindungen, verfahren zur herstellung derselben und antibakterielle mittel mit einem gehalt derselben.
DE2858813C2 (es)
DE1695790C3 (de) S-Phenoxythionocarbonylderivate des Vitamins B tief 1
DE1910283A1 (de) Arzneimittel mit einem Gehalt an (3,5,3',5'-Tetraoxo)-1,2-dipiperazinoalkanverbindungen und Verfahren zur Herstellung der Verbindungen
DE2164988C3 (de) 2,2-Diphenylcyclopropancarbonsäureesterderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0046565B1 (de) Neues Sparteinderivat, Verfahren zu seiner Herstellung, das Derivat enthaltende Arzneimittel und Verfahren zur Herstellung der Arzneimittel
DE2241076A1 (de) Tetracyclinkomplex, verfahren zu dessen herstellung und diesen komplex enthaltende pharmazeutische zusammensetzungen
AT286495B (de) Verfahren zur Herstellung von neuen Estern des α-Amino-benzylpenicillins
AT349453B (de) Verfahren zur herstellung von neuen aminoacetophenonderivaten und von deren salzen
CH645373A5 (de) 2-hydroxy-5-(1-hydroxy-2-(4-(2-oxo-1-benzimidazolinyl)-piperidino)ethyl)benzoesaeure-derivate sowie verfahren zu deren herstellung.
DE1960026A1 (de) Neue Derivate des 3-Amino-1,2-benzisothiazols und ein Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2035161C3 (de) L-Leucyl-L-leucyl-L-valyl-L-tyrosinol und seine Säureadditionssalze mit pharmakologisch unbedenklichen Säuren
AT339911B (de) Verfahren zur herstellung eines neuen 1-phthalazonderivates
DE1227462B (de) Verfahren zur Herstellung von Chinolinderivaten
DE2129991C3 (de) Verfahren zur Herstellung von 2-(4,5-Dihydro-5-propyl-2(3H)-furyliden) -1,3-cyclopentandion
DE1470284C (de) beta- geschweifte Klammer auf 1-Methyl-4- eckige Klammer auf l-methyl-4-(l-methyl-4-fonnylamino-pyrrol-2-carboxamido)-pyrrol-2-carboxamido eckige Klammer zu -pyrrol-2carboxamido geschweifte Klammer zu -propionamidin sowie dessen Säureadditionssalze
DE2223051A1 (de) D(+)-glucosamid der 1-(p-chlorbenzoyl)2-methyl-5-methoxy-indolyl-3-essigsaeure und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
PL Patent ceased